PRAX Overview
Upcoming Projects (PRAX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PRAX)
-
Unveiling the Potential of PRAX-628 in Epilepsy: A Comprehensive Look at Praxis Precision Medicines' Recent Study
Ticker: PRAX
Executed On: Apr 15, 2024 at 12:00 PM EDT -
Exploring the potential of PRAX-222 in patients with SCN2A gain-of-function developmental epilepsies.
Ticker: PRAX
Executed On: Feb 14, 2024 at 08:30 AM EST -
Exploring the potential of Praxis' PRAX-628 & PRAX-222 in focal epilepsy & early-onset epilepsy.
Ticker: PRAX
Executed On: Jan 30, 2024 at 11:00 AM EST -
A Second Look: Discussing Praxis' ulixacaltamide as a potential therapy in essential tremor
Ticker: PRAX
Executed On: Nov 30, 2023 at 03:30 PM EST -
Discussing Praxis' ulixacaltamide as a potential therapy in essential tremor
Ticker: PRAX
Executed On: Nov 28, 2023 at 01:30 PM EST -
A look at potential therapies in essential tremor, including PRAX-944 (T-type calcium channel blocker) and Suvecaltamide
Tickers: PRAX, JAZZ
Executed On: Nov 10, 2022 at 03:15 PM EST
Upcoming & Overdue Catalysts (PRAX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PRAX)
-
Praxis Precision Medicines (PRAX) Reports PRAX-114 Perimenopausal Depression (PMD) Phase 2a Proof-of-Concept Trial Results
Ticker: PRAX
Occurred on: Aug 16, 2021
Strategic Initiatives (PRAX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
